The Early Differentiation and Pipeline Strategy (EDAPS) team sits within the Global Medical Oncology organization under Global Medical Affairs and partners with Research and the Early Clinical Development teams within R&D. The team is responsible for the global Medical strategy for all hematology and oncology (HO) assets from candidate selection to clinical proof-of-concept (PoC) stage of the drug development cycle. The EDAPS Global Medical Lead is responsible for the development and execution of BMS’ global medical strategy for a subset of assets within the HO early development portfolio and is accountable to the early asset Development teams. The Lead will support the development of clinically differentiated compounds via interpretation of evolving pre-clinical & clinical data and engaging with thought leaders (TLs) early and often during the pre-POC phase of asset lifecycles.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior